Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6863d2854c1970de3d96ebcd",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "fluticasone furoate and vilanterol powder for inhalation",
"description": "FLUTICATONE VILO 100 is a combination inhalation therapy designed to manage and control chronic respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). This formulation contains two powerful agents: Fluticasone Furoate (100 mcg), a corticosteroid that reduces inflammation in the airways, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA) that helps in bronchodilation by relaxing airway muscles. Together, they provide long-term relief from symptoms like wheezing, shortness of breath, and chest tightness.\n\nThis powder is administered via inhalation, allowing targeted action directly at the site of inflammation and constriction, making it an effective and fast-acting treatment choice for those suffering from persistent asthma or airflow obstruction in COPD.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription medication used for long-term maintenance treatment of asthma and COPD in adults and adolescents. Fluticasone furoate is a synthetic corticosteroid that controls inflammation and swelling in the lungs. Vilanterol is a bronchodilator that improves breathing by relaxing muscles around the airways. The combination is not intended for acute bronchospasm relief but is ideal for daily use to manage chronic symptoms and prevent flare-ups.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term control of asthma symptoms such as wheezing, coughing, and breathlessness\n\nMaintenance treatment of COPD, including chronic bronchitis and emphysema\n\nPrevention of asthma exacerbations and hospitalizations\n\nImprovement in lung function and quality of life in chronic respiratory patients\n\nRegular use of this inhaler can help reduce dependency on rescue inhalers and lower the frequency of asthma attacks or COPD exacerbations.\n\nFluticasone Furoate and Vilanterol Powder for Inhalation Side Effects\nWhile generally well-tolerated, some users may experience mild to moderate side effects including:\n\nHeadache\n\nThroat irritation\n\nHoarseness of voice\n\nOral thrush (fungal infection in the mouth)\n\nCough or upper respiratory tract infections\n\nIncreased heart rate or palpitations\n\nMuscle cramps or tremors\n\nRare allergic reactions like rash, itching, or swelling\n\nTo minimize the risk of oral thrush, it is advised to rinse the mouth thoroughly after each inhalation.\n\nPrecautions Before Using FLUTICATONE VILO 100\nDo not use it to treat sudden asthma attacks; it is not a rescue inhaler.\n\nInform your doctor if you have a history of heart disease, high blood pressure, diabetes, or liver problems.\n\nUse with caution in pregnancy and breastfeeding; consult your physician.\n\nRegular monitoring of lung function and adrenal activity is recommended during long-term use.\n\nChildren and adolescents may require special dose adjustments under medical supervision.\n\nDrug Interactions: What Drugs Interact with Fluticasone Furoate and Vilanterol?\nSeveral medications may interact with this combination and alter its effectiveness or increase the risk of side effects:\n\nBeta-blockers (e.g., propranolol): May reduce the bronchodilatory effect of vilanterol\n\nKetoconazole or Ritonavir: These strong CYP3A4 inhibitors can increase the levels of fluticasone in the blood, raising the risk of side effects\n\nDiuretics: May increase the risk of hypokalemia when used with vilanterol\n\nOther corticosteroids: Concurrent use may enhance systemic corticosteroid side effects\n\nMAO inhibitors and Tricyclic Antidepressants: May amplify cardiovascular effects\n\nAlways inform your healthcare provider about any medications, supplements, or herbal products you are taking before starting FLUTICATONE VILO 100.\n\nConclusion\nFLUTICATONE VILO 100 is a scientifically advanced, dual-action inhalation therapy that provides effective long-term control for asthma and COPD. With the anti-inflammatory strength of fluticasone furoate 100 mcg and the bronchodilating effect of vilanterol 25 mcg, this combination ensures better breathing, fewer flare-ups, and improved quality of life. It’s a reliable and essential component in the chronic respiratory care of patients who need consistent symptom control and lung function improvement.",
"price": 525.0,
"discountamount": 158.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"combination ensures",
"improved quality",
"medications supplements",
"drugs interact",
"mouth cough",
"reduce dependency",
"synthetic corticosteroid",
"asthma attacks",
"asthma exacerbations",
"asthma symptoms",
"persistent asthma",
"vilanterol powder",
"controls inflammation",
"reduces inflammation",
"vilanterol ketoconazole",
"lungs vilanterol",
"vilanterol 25 mcg",
"essential component",
"bronchodilating effect",
"antiinflammatory strength",
"herbal products",
"healthcare provider",
"tricyclic antidepressants",
"corticosteroids concurrent",
"blood raising",
"bronchodilatory effect",
"adrenal activity",
"breastfeeding consult",
"liver problems",
"fluticatone vilo 100",
"oral thrush",
"rash itching",
"experience mild",
"generally welltolerated",
"emphysema prevention",
"wheezing coughing",
"prescription medication",
"airflow obstruction",
"constriction making",
"chest tightness",
"wheezing shortness",
"inhalation precautions",
"rescue inhalers",
"hospitalizations improvement",
"prevent flareups",
"improves breathing",
"fluticasone furoate",
"chronic bronchitis",
"lung function",
"relaxing muscles",
"rescue inhaler inform",
"adolescents fluticasone furoate",
"manage chronic symptoms",
"inhalation fluticasone furoate",
"lung function improvement",
"effective longterm control",
"breathing fewer flareups",
"inhalation longterm control",
"relaxing airway muscles",
"inhalation side effects",
"longterm maintenance treatment",
"provide longterm relief",
"chronic respiratory care",
"consistent symptom control",
"amplify cardiovascular effects",
"side effects diuretics",
"strong cyp3a4 inhibitors",
"side effects betablockers",
"physician regular monitoring",
"palpitations muscle cramps",
"moderate side effects",
"breathlessness maintenance treatment",
"acute bronchospasm relief",
"fastacting treatment choice"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2139,
"imageuri": "https://productimages.withfloats.com/actual/6863d28eeb66715cb5e18de8.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6863d28eeb66715cb5e18de8.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-01T12:20:21.253Z",
"updatedon": "2026-03-14T08:43:27.599Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//fluticasone-furoate-and-vilanterol-powder-for-inhalation/2139",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "FLUTICATONE VILO 100",
"category": "ASTHMARANGE",
"tags": [
"fluticasone furoate and vilanterol powder for inhalation",
"Chronic Obstructive Pulmonary Disease (COPD).",
"relaxing airway muscles.",
"shortness of breath.",
"chest tightness.",
"lung function improvement."
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "682b13fdab5024c71f212646",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "amoxicillin 200 mg and clavulanic acid 28.5 mg",
"description": "CLAVAMOXY LS ORAL SUSPENSION is a pediatric antibiotic formulation designed to treat various bacterial infections in children. It combines Amoxycillin, a broad-spectrum penicillin antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor that enhances Amoxycillin’s effectiveness. This combination provides powerful protection against bacteria that have developed resistance to standard antibiotics. It is commonly prescribed for respiratory tract infections, urinary tract infections, skin infections, and ear infections in children.\n\nKey Ingredients\nAmoxycillin (200mg)\n\nA widely used penicillin-type antibiotic that fights bacteria by inhibiting their cell wall synthesis.\n\nEffective against both gram-positive and gram-negative bacteria.\n\nClavulanic Acid (28.5mg)\n\nA beta-lactamase inhibitor that prevents bacterial enzymes from breaking down Amoxycillin.\n\nBroadens the spectrum of antibacterial activity.\n\nSterile Water for Injections IP (30 ml)\n\nActs as a solvent to reconstitute the dry powder before administration.\n\nEnsures accurate dosing and safe oral delivery.\n\nKey Benefits\nProvides a broad-spectrum antibacterial effect suitable for a variety of infections.\n\nEspecially effective in treating infections caused by beta-lactamase producing bacteria.\n\nFormulated as a liquid suspension, making it easy to administer to infants and children.\n\nOffers fast relief from symptoms like fever, pain, and inflammation related to infections.\n\nHelps prevent the recurrence of infections by eliminating the root cause.\n\nHow Does It Work?\nCLAVAMOXY LS ORAL SUSPENSION works through a dual mechanism:\n\nAmoxycillin interferes with the bacteria's ability to form cell walls, leading to the breakdown and death of the bacteria.\n\nClavulanic Acid prevents the bacteria from producing beta-lactamase enzymes, which are responsible for resisting many antibiotics.\n\nTogether, they make a potent combination that overcomes antibiotic resistance and ensures effective treatment.\n\nDirections for Use\nShake the bottle well before each use to ensure uniform suspension.\n\nAdminister the prescribed dose using a measuring spoon or syringe provided with the medication.\n\nDosage should be based on body weight and the severity of infection, as directed by a pediatrician.\n\nIt is usually taken every 8 or 12 hours, depending on the child’s medical condition.\n\nComplete the full course even if the child starts feeling better to prevent bacterial resistance.\n\nStore the reconstituted suspension in a refrigerator and use within the specified time frame (typically 7 days).\n\nDo not freeze and keep it out of reach of children.\n\nSide Effects\nDiarrhea – commonly due to changes in gut bacteria.\n\nNausea or vomiting – especially if taken on an empty stomach.\n\nSkin rash or itching – may indicate an allergic reaction.\n\nAbdominal pain or bloating – usually mild and temporary.\n\nThrush (oral fungal infection) – may occur with prolonged use.\n\nSevere allergic reactions (rare) – such as difficulty breathing or swelling of face/lips should be reported immediately.\n",
"price": 155.0,
"discountamount": 47.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"potent combination",
"standard antibiotics",
"fights bacteria",
"reported immediately",
"difficulty breathing",
"12 hours depending",
"body weight",
"medication dosage",
"syringe provided",
"measuring spoon",
"prescribed dose",
"bacterias ability",
"inflammation related",
"fever pain",
"dry powder",
"amoxycillin broadens",
"ear infections",
"commonly prescribed",
"powerful protection",
"clavulanic acid",
"combines amoxycillin",
"betalactamase inhibitor",
"reconstituted suspension",
"developed resistance",
"bacterial infections",
"penicillintype antibiotic",
"gut bacteria nausea",
"infections helps prevent",
"treating infections caused",
"overcomes antibiotic resistance",
"producing betalactamase enzymes",
"liquid suspension making",
"prevents bacterial enzymes",
"broadspectrum penicillin antibiotic",
"child starts feeling",
"enhances amoxycillins effectiveness"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2120,
"imageuri": "https://productimages.withfloats.com/actual/682b13feb64aa3208ac3eabe.png",
"tileimageuri": "https://productimages.withfloats.com/tile/682b13feb64aa3208ac3eabe.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-05-19T11:20:29.495Z",
"updatedon": "2026-03-12T07:29:45.913Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//amoxicillin-200-mg-and-clavulanic-acid-28-5-mg/2120",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Steris Healthcare Pvt Ltd",
"category": "PEDIATRICS",
"tags": [
"Amoxicillin 200mg potassium clavulanate 28.5 mg 5ml oral suspension",
"Amoxicillin and potassium clavulanate syrup dose for child",
"Amoxicillin Clavulanate brand names in India",
"atorvastatin 10mg + clopidogrel 75 mg brands"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "67fce9015a26e4010ea412f4",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Amoxycillin 400mg and Clavulanic Acid 57mg",
"description": "CLAVAMOXY DS ORAL SUSPENSION is an antibiotic formulation specifically optimized for children. It contains Amoxycillin with a broad-spectrum antibacterial effect and Clavulanic Acid, which inhibits beta-lactamase enzymes. With this dual mechanism of action, it efficaciously manages a wide variety of infections in children, including respiratory infections, otitis media, sinusitis, urinary tract infections, or even skin infections.\n\nKey Benefits:\n\nDelivers sufficient antibacterial coverage for a myriad of infections.\nClavulanic Acid augments Amoxycillin’s activity by preventing resistance from Acinetobacter spp.\nEffective in treating respiratory tract infections as well as urinary infections in children.\nPediatric friendly formulation with a good taste to improve compliance.\nQuicker recovery and faster, effective alleviation of symptoms.\n\nHow Does It Work:\n\nAmoxycillin, being a penicillin antibiotic, works by destroying the bacteria cell wall leading to its death. However, some bacteria synthesize an enzyme beta-lactamase that would nullify the effects of Amoxycillin. Inhibiting this enzyme, Clavulanic Acid saves Amoxycillin and helps it get the job done more effectively. Together, they provide combined synergistic action against stubborn bacteria.\n\nDirections for Use:\nShake the bottle well before each use.\nUse the measuring spoon or cup provided to ensure accurate dosing.\nAs directed by the pediatrician, the dosage should be given according to the child’s weight and age.\nGiven with food may lessen the risk of upset stomach.\nTo avoid bacterial resistance, complete the full course even if the child feels better.\n\nSide Effects:\nCommon side effects may include mild diarrhea, nausea, vomiting, or rash.\nChildren may infrequently have allergic reactions such as itching or swelling.\nIf severe side effects arise like persistent diarrhea or difficulty breathing, inform the doctor immediately.\nMake sure to consult the pediatrician regarding any unusual symptoms during the treatment.\n",
"price": 165.0,
"discountamount": 50.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"rash children",
"unusual symptoms",
"urinary infections",
"amoxycillin inhibiting",
"work amoxycillin",
"amoxycillin 400mg",
"persistent diarrhea",
"allergic reactions",
"child feels",
"upset stomach",
"childs weight",
"cup provided",
"measuring spoon",
"good taste",
"preventing resistance",
"wide variety",
"efficaciously manages",
"dual mechanism",
"clavulanic acid",
"enzyme betalactamase",
"bacteria synthesize",
"stubborn bacteria directions",
"inhibits betalactamase enzymes",
"doctor immediately make",
"difficulty breathing inform",
"ensure accurate dosing",
"penicillin antibiotic works",
"faster effective alleviation",
"acinetobacter spp effective",
"broadspectrum antibacterial effect"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2081,
"imageuri": "https://productimages.withfloats.com/actual/67fce904ff16712e7c792183.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67fce904ff16712e7c792183.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-04-14T10:52:49.79Z",
"updatedon": "2026-03-12T07:27:16.249Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//amoxycillin-400mg-and-clavulanic-acid-57mg/2081",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CLAVAMOXY DS ORAL SUSPENSION",
"category": "PEDIATRICS",
"tags": [
"Amoxicillin and Clavulanic Acid combination brand name",
"Amoxicillin 500mg Clavulanic acid 125mg Price",
"Amoxicillin Clavulanate brand names in India"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6ad7442bf24c5a4bbccf4b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets",
"description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.",
"price": 230.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2504,
"imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:36:27.325Z",
"updatedon": "2026-10-20T10:36:27.325Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 25",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a1d7da71f450faabc228b8d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "gliclazide sr 60mg and Dapagliflozin 10mg tablet",
"description": "Managing Type 2 diabetes requires a comprehensive approach that helps control blood sugar levels while reducing the risk of long-term complications. The Gliclazide and Dapagliflozin combination is a modern and effective treatment option prescribed by healthcare professionals to improve glycemic control in adults with Type 2 diabetes mellitus. This combination works through two different mechanisms to help maintain healthy blood glucose levels, making it a preferred choice for patients who need better diabetes management.\n\nIf you are looking for a reliable diabetes treatment option, understanding the benefits, uses, and working mechanism of the Gliclazide and Dapagliflozin combination can help you make an informed decision in consultation with your healthcare provider.\n\nWhat is Gliclazide and Dapagliflozin Combination?\n\nThe Gliclazide and Dapagliflozin combination is an oral anti-diabetic medication used to control blood sugar levels in patients with Type 2 diabetes. It combines two powerful medicines:\n\nGliclazide – A sulfonylurea that stimulates the pancreas to release more insulin.\nDapagliflozin – An SGLT2 inhibitor that helps the kidneys remove excess glucose through urine.\n\nTogether, these medicines provide dual-action blood sugar control and help patients achieve better glycemic targets when diet, exercise, and single-drug therapy are insufficient.\n\nHow Does Gliclazide and Dapagliflozin Combination Work?\n\nThe effectiveness of this combination lies in its complementary mechanisms of action.\n\nGliclazide Action\n\nGliclazide works by stimulating the beta cells in the pancreas to produce and release more insulin. Increased insulin production helps transport glucose from the bloodstream into body cells, where it is used for energy.\n\nDapagliflozin Action\n\nDapagliflozin blocks the Sodium-Glucose Co-Transporter 2 (SGLT2) protein in the kidneys. This action reduces glucose reabsorption and allows excess sugar to be eliminated through urine, lowering blood glucose levels.\n\nCombined Benefits\n\nWhen used together, Gliclazide and Dapagliflozin help:\n\nReduce fasting blood sugar levels\nLower post-meal glucose spikes\nImprove HbA1c levels\nSupport long-term diabetes management\nProvide complementary glucose-lowering effects\nUses of Gliclazide and Dapagliflozin Combination\n\nHealthcare professionals commonly prescribe this combination for:\n\nType 2 Diabetes Mellitus\n\nThe primary use of the Gliclazide and Dapagliflozin combination is the treatment of Type 2 diabetes in adults whose blood sugar levels are not adequately controlled by lifestyle modifications alone.\n\nImproved Glycemic Control\n\nThis medication helps patients achieve better glycemic control and maintain stable blood glucose levels throughout the day.\n\nCombination Diabetes Therapy\n\nIt is often recommended when monotherapy with a single anti-diabetic medication fails to provide satisfactory results.\n\nLong-Term Diabetes Management\n\nThe combination can be used as part of a comprehensive diabetes management plan that includes healthy eating, exercise, and regular monitoring.\n\nBenefits of Gliclazide and Dapagliflozin Combination\n1. Dual Mechanism of Action\n\nThe combination attacks high blood sugar from two different angles, resulting in more effective glucose control.\n\n2. Better HbA1c Reduction\n\nPatients often experience significant reductions in HbA1c levels compared to treatment with a single medication.\n\n3. Effective Fasting and Postprandial Control\n\nThe medicine helps manage both fasting blood glucose and post-meal sugar spikes.\n\n4. Convenient Treatment Option\n\nCombining two medications into one treatment regimen can improve patient compliance and simplify diabetes management.\n\n5. Supports Weight Management\n\nUnlike some traditional diabetes medications, Dapagliflozin may contribute to modest weight reduction due to the elimination of excess glucose through urine.\n\n6. Cardiovascular Benefits\n\nDapagliflozin has been associated with cardiovascular benefits in certain patients, making it an attractive option for individuals with Type 2 diabetes and cardiovascular risk factors.\n\n7. Reduced Risk of Diabetes Complications\n\nMaintaining better blood sugar control may help reduce the risk of complications affecting the eyes, kidneys, nerves, and cardiovascular system.\n\nWhy Choose Gliclazide and Dapagliflozin Combination?\n\nThe growing popularity of this combination therapy stems from its ability to provide comprehensive blood sugar management. Physicians often recommend it because:\n\nIt targets multiple pathways involved in glucose regulation.\nIt provides strong glycemic control.\nIt helps reduce HbA1c effectively.\nIt offers potential weight-related benefits.\nIt supports long-term diabetes care goals.\n\nPatients seeking improved diabetes control often find this combination beneficial when prescribed and monitored by a healthcare professional.\n\nRecommended Dosage\n\nThe dosage of the Gliclazide and Dapagliflozin combination should always be determined by a healthcare provider based on:\n\nAge\nBlood glucose levels\nHbA1c values\nMedical history\nKidney function\nResponse to treatment\n\nPatients should take the medication exactly as prescribed and should not alter the dosage without medical advice.\n\nPrecautions Before Using Gliclazide and Dapagliflozin Combination\n\nBefore starting treatment, inform your doctor if you have:\n\nKidney disease\nLiver disorders\nHeart conditions\nFrequent urinary tract infections\nHistory of diabetic ketoacidosis\nSevere dehydration\nLow blood pressure\n\nPregnant and breastfeeding women should consult their healthcare provider before using this medication.\n\nPossible Side Effects\n\nLike all medications, the Gliclazide and Dapagliflozin combination may cause side effects in some individuals.\n\nCommon Side Effects\nIncreased urination\nThirst\nHeadache\nDizziness\nFatigue\nMild gastrointestinal discomfort\nHypoglycemia Symptoms\n\nSince Gliclazide stimulates insulin release, some patients may experience low blood sugar, especially when meals are skipped.\n\nSymptoms may include:\n\nSweating\nHunger\nTrembling\nWeakness\nConfusion\nRapid heartbeat\nUrinary and Genital Infections\n\nDapagliflozin increases glucose excretion through urine, which may increase the likelihood of:\n\nUrinary tract infections\nGenital fungal infections\n\nPrompt medical attention should be sought if symptoms occur.\n\nLifestyle Tips for Better Diabetes Control\n\nFor optimal results with the Gliclazide and Dapagliflozin combination, patients should follow a healthy lifestyle.\n\nMaintain a Balanced Diet\n\nFocus on:\n\nWhole grains\nVegetables\nFruits in moderation\nLean proteins\nHealthy fats\n\nAvoid excessive consumption of sugary foods and beverages.\n\nExercise Regularly\n\nPhysical activity helps improve insulin sensitivity and supports blood sugar control. Aim for at least 150 minutes of moderate exercise per week, as advised by your healthcare provider.\n\nMonitor Blood Sugar\n\nRegular blood glucose monitoring helps track treatment effectiveness and allows timely adjustments when necessary.\n\nStay Hydrated\n\nBecause Dapagliflozin increases urinary glucose excretion, adequate hydration is important to prevent dehydration.\n\nAttend Regular Checkups\n\nRoutine medical visits help monitor:\n\nHbA1c levels\nKidney function\nBlood pressure\nOverall diabetes control\nWho Can Benefit from Gliclazide and Dapagliflozin Combination?\n\nThis combination may be suitable for:\n\nAdults with Type 2 diabetes\nPatients requiring stronger glucose control\nIndividuals not achieving targets with single-drug therapy\nPatients seeking a dual-action diabetes treatment approach\nIndividuals requiring comprehensive glycemic management under medical supervision\nConclusion\n\nThe Gliclazide and Dapagliflozin combination is an advanced and effective treatment option for adults with Type 2 diabetes mellitus. By combining the insulin-stimulating action of Gliclazide with the glucose-eliminating benefits of Dapagliflozin, this therapy provides comprehensive blood sugar control and supports long-term diabetes management goals.\n\nWith benefits such as improved HbA1c reduction, fasting and post-meal glucose control, convenient therapy, and potential cardiovascular advantages, this combination has become an important choice in modern diabetes care. When used alongside a healthy diet, regular exercise, and proper medical supervision, the Gliclazide and Dapagliflozin combination can help patients achieve better glycemic control and improve their overall quality of life.",
"price": 470.0,
"discountamount": 141.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2433,
"imageuri": "https://productimages.withfloats.com/actual/6a1d7da92f2aa2676dd01915.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a1d7da92f2aa2676dd01915.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-06-01T12:40:07.196Z",
"updatedon": "2026-06-04T07:19:16.331Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//gliclazide-sr-60mg-and-dapagliflozin-10mg-tablet/2433",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Gliclaglaze DAPA 60-10",
"category": "DIABETIC RANGE",
"tags": [
"gliclazide and dapagliflozin combination",
"gliclazide sr 60mg and Dapagliflozin 10mg tablet",
"gliclazide and dapagliflozin",
"gliclazide and dapagliflozin together",
"gliclazide dapagliflozin",
"Gliclazide SR 60 mg and Dapagliflozin 10 mg Tablets",
"Buy Gliclazide SR 60 mg Dapagliflozin 10 mg Tablets Online",
"Type 2 Diabetes Treatment Tablets",
"Gliclazide and Dapagliflozin Diabetes Medicine",
"Gliclazide SR 60 mg Dapagliflozin 10 mg Product Image",
"Best Tablets for Type 2 Diabetes Management",
"Blood Sugar Control Tablets Gliclazide Dapagliflozin",
"Gliclazide SR and Dapagliflozin Combination Tablets",
"Diabetes Management Medicine Gliclazide Dapagliflozin"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a03166b3678f86a626aca60",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "glycopyrrolate formoterol fumarate and budesonide inhalation",
"description": "Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation\nWhen patients and healthcare providers search for a reliable inhalation therapy for chronic respiratory conditions, Glycopyrrolate + Formoterol Fumarate + Budesonide inhalation stands out as a modern triple-combination treatment designed to support long-term breathing management. This combination is commonly prescribed in patients requiring advanced maintenance therapy for chronic airway obstruction and inflammation.\nThe three active ingredients work together to help open the airways, reduce inflammation, and improve overall lung function. Triple-combination inhalation therapy is widely used in chronic respiratory management and is commonly prescribed for adults needing long-term control of airway symptoms. \nWhat is Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation?\nThis inhalation contains three clinically proven medicines:\n1. Glycopyrrolate\nGlycopyrrolate helps relax airway muscles by blocking muscarinic receptors. This action keeps air passages open for easier breathing.\n2. Formoterol Fumarate\nFormoterol is a long-acting bronchodilator that helps maintain airway relaxation for extended periods.\n3. Budesonide\nBudesonide reduces airway inflammation, swelling, and irritation, helping lower flare-ups in chronic respiratory disease.\nTogether, these three medicines create a comprehensive treatment option for respiratory maintenance therapy. \nKey Buyer Benefits of This Inhalation\nHealthcare professionals and procurement teams often choose this inhalation because of its multiple benefits:\nSuperior Triple Action\nInstead of prescribing multiple inhalers, this triple combination provides three therapeutic actions in one inhalation device.\nImproved Lung Function\nPatients may experience better airflow and improved breathing comfort with regular prescribed use.\nReduced Respiratory Flare-Ups\nClinical use shows that triple therapy can help reduce worsening episodes in chronic airway disease. \nBetter Patient Compliance\nA single inhaler may improve convenience and adherence to treatment plans.\nCommon Uses of Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation\nThis inhalation is commonly prescribed for:\n\n\nChronic Obstructive Pulmonary Disease (COPD)\n\n\nChronic bronchitis\n\n\nAirflow limitation disorders\n\n\nLong-term respiratory maintenance therapy\n\n\nPhysician-directed asthma maintenance in appropriate patients\n\n\nThis medicine is for maintenance treatment and is not intended for immediate relief of sudden breathing attacks. \nHow Does This Triple Combination Work?\nEach component contributes differently:\nGlycopyrrolate reduces airway tightening.\nFormoterol Fumarate keeps air passages open for longer periods.\nBudesonide controls airway inflammation.\nThis combined mechanism helps support easier breathing and better respiratory stability.\nWhy Buyers Choose This Product\nHospitals, distributors, pharmacies, and healthcare procurement teams often look for products that offer:\n\n\nHigh therapeutic value\n\n\nReliable respiratory support\n\n\nEasy inhalation administration\n\n\nReduced need for multiple inhalers\n\n\nStrong physician acceptance\n\n\nBecause this product combines anti-inflammatory and bronchodilator benefits, it remains a preferred respiratory care option.\nDosage and Administration\nThe exact dosage should always be prescribed by a healthcare professional.\nTypical maintenance inhalation regimens are taken twice daily depending on formulation and clinical need. Patients should rinse their mouth after use to help reduce local side effects. \nImportant Usage Tips\n\n\nShake inhaler before use\n\n\nUse exactly as prescribed\n\n\nDo not exceed recommended doses\n\n\nPrime inhaler if instructed\n\n\nStore in a cool and dry place\n\n\nPossible Side Effects\nLike all prescription medicines, some users may experience side effects such as:\n\n\nDry mouth\n\n\nThroat irritation\n\n\nHoarseness\n\n\nMild cough\n\n\nHeadache\n\n\nOral fungal infection\n\n\nFast heartbeat in some patients\n\n\nMost effects are manageable under medical supervision. \nSafety Precautions\nBefore using this inhalation, patients should inform their doctor if they have:\n\n\nHeart disease\n\n\nHigh blood pressure\n\n\nDiabetes\n\n\nThyroid disorders\n\n\nKidney problems\n\n\nLiver disease\n\n\nGlaucoma\n\n\nPregnant or breastfeeding patients should use it only under medical supervision.\nPackaging and Commercial Availability\nThis product is generally available in metered-dose inhaler packaging suitable for:\n\n\nHospitals\n\n\nMedical distributors\n\n\nExport buyers\n\n\nRetail pharmacies\n\n\nRespiratory specialty clinics\n\n\nBulk procurement options may be available depending on manufacturer and supply chain requirements.\nWhy This Inhalation is a Smart Healthcare Purchase\nFor medical buyers and respiratory specialists, Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation offers:\n\n\nTriple mechanism support\n\n\nTrusted respiratory treatment profile\n\n\nStrong prescription demand\n\n\nGrowing market acceptance\n\n\nLong-term patient care utility\n\n\nConclusion\nIf you are searching for an advanced respiratory maintenance solution, Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation delivers comprehensive airway support through bronchodilation and anti-inflammatory action. Whether for hospital procurement, pharmacy distribution, or physician prescribing needs, this triple-combination inhalation remains a high-demand therapeutic option in respiratory medicine.\n",
"price": 885.0,
"discountamount": 266.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2417,
"imageuri": "https://productimages.withfloats.com/actual/6a03166ee67a7c906d87cf8d.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a03166ee67a7c906d87cf8d.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-05-12T12:00:43.79Z",
"updatedon": "2026-06-04T07:57:03.191Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//glycopyrrolate-formoterol-fumarate-and-budesonide-inhalation/2417",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "BUDEPRESS PLUS INH",
"category": "ASTHMARANGE",
"tags": [
"glycopyrrolate formoterol fumarate and budesonide inhalation",
"buy budesonide glycopyrrolate formoterol fumarate",
"budesonide glycopyrrolate formoterol fumarate",
"glycopyrrolate formoterol fumarate",
"Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation",
"Buy Glycopyrrolate Formoterol Budesonide Inhaler Online",
"Triple Combination Inhaler for COPD Treatment",
"Asthma Treatment Inhaler with Budesonide and Formoterol",
"Budesonide Formoterol Glycopyrrolate Inhalation Therapy",
"Prescription Inhaler for COPD and Asthma Management",
"Glycopyrrolate Formoterol Budesonide Inhaler Product Image",
"Best Triple Therapy Inhaler for Breathing Disorders",
"Budesonide Glycopyrrolate Formoterol Inhaler for Lung Care",
"Budesonide, glycopyrrolate, formoterol brand name",
"glycopyrrolate formoterol fumarate and budesonide inhalation in hindi",
"glycopyrrolate formoterol fumarate and budesonide inhalation price",
"glycopyrrolate formoterol fumarate and budesonide inhalation price in india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69f88189c66d1e2560186d5b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "bempedoic acid and ezetimibe tablets",
"description": "If you’re looking for an effective way to manage high cholesterol and reduce your cardiovascular risk, bempedoic acid and ezetimibe tablets may be exactly what your doctor recommends. This powerful combination therapy is designed for individuals who need additional LDL cholesterol reduction beyond diet, lifestyle changes, or even statin therapy.\n\nThis buyer-intent guide will help you understand how bempedoic acid and ezetimibe tablets work, their benefits, uses, dosage, side effects, and what to consider before purchasing—so you can make an informed decision.\n\nWhat Are Bempedoic Acid and Ezetimibe Tablets?\n\nBempedoic acid and ezetimibe tablets are a combination medication used to lower bad cholesterol (LDL-C) levels in the blood. They are typically prescribed for:\n\nPatients with hypercholesterolemia (high cholesterol)\nIndividuals who cannot tolerate high-dose statins\nPatients needing additional LDL reduction alongside statins\nComposition:\nBempedoic Acid – Reduces cholesterol production in the liver\nEzetimibe – Reduces cholesterol absorption from the intestine\n\nTogether, they provide a dual-action approach to cholesterol management.\n\nHow Do Bempedoic Acid and Ezetimibe Tablets Work?\n\nThis combination targets cholesterol from two different pathways:\n\n1. Bempedoic Acid Mechanism\nInhibits ATP citrate lyase (ACL), an enzyme involved in cholesterol synthesis\nReduces LDL cholesterol production in the liver\nWorks upstream of statins but with a different activation pathway\n2. Ezetimibe Mechanism\nBlocks cholesterol absorption in the small intestine\nReduces the amount of dietary and biliary cholesterol entering the bloodstream\nCombined Effect:\nSignificant reduction in LDL cholesterol\nImproved lipid profile\nLower risk of plaque formation in arteries\nKey Uses of Bempedoic Acid and Ezetimibe Tablets\n\nThis medication is prescribed for:\n\nPrimary hyperlipidemia (high cholesterol)\nMixed dyslipidemia\nPatients at high cardiovascular risk\nIndividuals not achieving LDL targets with statins alone\n\nIt is usually combined with a heart-healthy diet and lifestyle changes.\n\nWhy Choose Bempedoic Acid and Ezetimibe Tablets?\n✔ Dual Mechanism Action\n\nTargets both cholesterol production and absorption for enhanced effectiveness.\n\n✔ Ideal for Statin-Intolerant Patients\n\nSuitable for individuals who cannot tolerate high-dose statins.\n\n✔ Significant LDL Reduction\n\nHelps achieve target cholesterol levels faster.\n\n✔ Cardiovascular Protection\n\nReduces the risk of heart attack, stroke, and other heart-related complications.\n\nBenefits of Bempedoic Acid and Ezetimibe Tablets\n1. Effective Cholesterol Control\n\nHelps lower LDL cholesterol significantly compared to single-drug therapy.\n\n2. Supports Heart Health\n\nReduces plaque buildup in arteries and improves overall cardiovascular function.\n\n3. Convenient Combination Therapy\n\nTwo medications in one tablet improve compliance.\n\n4. Complementary to Statins\n\nCan be used alongside statins for better results.\n\n5. Alternative for Sensitive Patients\n\nUseful for those experiencing statin-related muscle issues.\n\nDosage and Administration\nTake bempedoic acid and ezetimibe tablets exactly as prescribed\nUsually taken once daily, with or without food\nSwallow the tablet whole with water\nImportant Tips:\nTake at the same time every day\nDo not skip doses\nFollow your doctor’s instructions strictly\nPossible Side Effects\n\nLike any medication, this combination may cause side effects.\n\nCommon Side Effects:\nUpper respiratory tract infections\nMuscle spasms\nBack pain\nAbdominal discomfort\nElevated liver enzymes\nLess Common Side Effects:\nFatigue\nJoint pain\nIncreased uric acid levels\nSerious Side Effects (Rare):\nTendon rupture\nSevere allergic reactions\nLiver dysfunction\n\n⚠️ Seek medical help if you experience unusual or severe symptoms.\n\nPrecautions Before Buying\n\nBefore purchasing or using bempedoic acid and ezetimibe tablets, consider:\n\nInform your doctor if you have liver disease or kidney issues\nAvoid use during pregnancy or breastfeeding unless prescribed\nMonitor cholesterol and liver function regularly\nInform your doctor about all medications you are taking\nWho Should Not Use This Medication?\n\nAvoid this medication if:\n\nYou are allergic to any of its components\nYou have severe liver disease\nYou are pregnant without medical supervision\n\nAlways consult your healthcare provider before starting treatment.\n\nBuying Guide: Bempedoic Acid and Ezetimibe Tablets\n\nWhen buying this medication, keep these points in mind:\n\n✔ Purchase from Trusted Sources\n\nOnly buy from licensed pharmacies or verified online platforms.\n\n✔ Prescription Required\n\nThis is a prescription medicine—do not self-medicate.\n\n✔ Check Packaging\n\nVerify authenticity, expiry date, and manufacturer details.\n\n✔ Compare Brands\n\nChoose a reputable brand known for quality and reliability.\n\nStorage Instructions\nStore in a cool, dry place\nKeep away from moisture and sunlight\nKeep out of reach of children\nLifestyle Tips for Better Results\n\nFor maximum effectiveness:\n\nFollow a low-fat, heart-healthy diet\nExercise regularly\nAvoid smoking and excessive alcohol\nMaintain a healthy weight\nMonitor cholesterol levels periodically\n\nFrequently Asked Questions \n\nQ1. What are bempedoic acid and ezetimibe tablets used for?\n\nThey are used to lower LDL cholesterol and reduce cardiovascular risk.\n\nQ2. Can I take it with statins?\n\nYes, it is often prescribed alongside statins for better cholesterol control.\n\nQ3. How long does it take to show results?\n\nYou may see improvements in cholesterol levels within a few weeks.\n\nQ4. Is it safe for long-term use?\n\nYes, under medical supervision.\n\nQ5. Can I buy it online?\n\nYes, but only from authorized pharmacies with a valid prescription.\n\nConclusion\n\nBempedoic acid and ezetimibe tablets offer a modern, effective solution for managing high cholesterol, especially for patients who need additional support beyond traditional therapies. With its dual-action mechanism, proven benefits, and convenient dosing, this combination is a valuable option in cardiovascular care.",
"price": 300.0,
"discountamount": 90.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2400,
"imageuri": "https://productimages.withfloats.com/actual/69f8818bdd688c83fed29982.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69f8818bdd688c83fed29982.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-05-04T11:22:49.066Z",
"updatedon": "2026-05-23T06:36:45.947Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//bempedoic-acid-and-ezetimibe-tablets/2400",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "BEMPIDOC EZ 180/10",
"category": "CARDIOLOGYRANGE",
"tags": [
"bempedoic acid and ezetimibe tablets",
"bempedoic acid and ezetimibe tablets 180 mg/10 mg",
"bempedoic acid and ezetimibe tablets uses"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69f1f2ab0401258bafb82cd7",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets",
"description": "Managing type 2 diabetes effectively often requires a combination of medicines that work together to control blood sugar levels. DAPAVILDA MET 10/100/500 is a powerful triple-combination tablet formulated with Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 500 mg Tablets. This advanced formulation is designed to help adults with type 2 diabetes maintain better glucose control, improve insulin response, and support overall metabolic health.\n\nIf you are looking for a trusted diabetes management tablet, DAPAVILDA MET 10/100/500 offers a convenient once-daily option under medical supervision.\n\nWhat is DAPAVILDA MET 10/100/500?\n\nDAPAVILDA MET 10/100/500 is a combination medicine used to treat Type 2 Diabetes Mellitus when diet, exercise, or single-drug therapy is not enough to control blood sugar. It contains three clinically proven ingredients:\n\nDapagliflozin 10 mg – Helps remove excess sugar through urine.\nVildagliptin SR 100 mg – Enhances insulin secretion and reduces glucagon release.\nMetformin SR 500 mg – Reduces glucose production in the liver and improves insulin sensitivity.\n\nThis triple-action therapy helps patients achieve better glycemic control and reduces diabetes-related complications.\n\nHow DAPAVILDA MET 10/100/500 Works\n1. Dapagliflozin 10 mg\n\nDapagliflozin belongs to the SGLT2 inhibitor class. It works by blocking glucose reabsorption in the kidneys, allowing excess sugar to pass out through urine. This helps lower blood sugar naturally.\n\n2. Vildagliptin SR 100 mg\n\nVildagliptin is a DPP-4 inhibitor that increases incretin hormone levels. These hormones stimulate insulin release after meals and reduce unnecessary glucose production.\n\n3. Metformin SR 500 mg\n\nMetformin is one of the most trusted diabetes medicines. It decreases glucose production in the liver and improves the body's response to insulin.\n\nTogether, these ingredients provide comprehensive blood sugar management throughout the day.\n\nUses of DAPAVILDA MET 10/100/500\n\nDAPAVILDA MET 10/100/500 Tablets are primarily used for:\n\n✔ Type 2 Diabetes Mellitus\n\nHelps manage high blood sugar levels in adults with type 2 diabetes.\n\n✔ Poorly Controlled Diabetes\n\nUseful when blood sugar remains high despite lifestyle changes or single/dual therapy.\n\n✔ Reduction of HbA1c Levels\n\nSupports long-term sugar control and helps reduce HbA1c.\n\n✔ Weight Management Support\n\nDapagliflozin may assist in mild weight reduction in some diabetic patients.\n\n✔ Improved Metabolic Health\n\nHelps improve insulin sensitivity and glucose utilization.\n\nKey Benefits of DAPAVILDA MET 10/100/500\n1. Triple Combination Formula\n\nThree effective medicines in one tablet for better sugar control.\n\n2. Better Fasting and Post-Meal Sugar Control\n\nHelps control both fasting blood sugar and postprandial spikes.\n\n3. Convenient Once Daily Dosage\n\nSustained release formula supports long-lasting action.\n\n4. Supports Weight Balance\n\nMay help reduce calorie overload through urinary glucose excretion.\n\n5. Helps Lower Risk of Diabetes Complications\n\nGood sugar control may reduce risk of kidney, nerve, eye, and heart problems.\n\n6. Improves Insulin Function\n\nSupports natural insulin release when needed.\n\nWho Can Use DAPAVILDA MET 10/100/500?\n\nThis medicine may be prescribed for:\n\nAdults with type 2 diabetes\nPatients needing triple-drug therapy\nOverweight diabetic individuals\nPatients with uncontrolled HbA1c\nIndividuals requiring convenient once-daily medication\n\nAlways use only after doctor consultation.\n\nRecommended Dosage\n\nThe dosage of DAPAVILDA MET 10/100/500 should be decided by a physician depending on:\n\nBlood sugar levels\nHbA1c results\nKidney function\nExisting medications\nOverall health condition\nGeneral Advice:\nTake with food to reduce stomach upset.\nSwallow whole with water.\nDo not crush or chew SR tablet.\nTake at the same time daily.\nSide Effects of DAPAVILDA MET 10/100/500\n\nLike all medicines, some users may experience mild side effects.\n\nCommon Side Effects\nNausea\nStomach discomfort\nFrequent urination\nHeadache\nLoose stools\nDizziness\nLow appetite\nLess Common Side Effects\nUrinary tract infection\nGenital fungal infection\nDehydration\nWeakness\nSerious Side Effects (Need Immediate Medical Help)\nSevere low sugar (if used with insulin/sulfonylureas)\nLactic acidosis (rare)\nAllergic reaction\nSevere dehydration\nKidney problems\n\nIf unusual symptoms appear, contact a doctor immediately.\n\nPrecautions and Warnings\n\nBefore using DAPAVILDA MET 10/100/500, inform your doctor if you have:\n\nKidney disease\nLiver disease\nHeart problems\nFrequent urinary infections\nHistory of pancreatitis\nAlcohol dependency\nPregnancy or breastfeeding\nImportant:\n\nStay hydrated while taking dapagliflozin-containing medicines.\n\nLifestyle Tips for Better Results\n\nMedicine works best with healthy habits:\n\n✔ Follow a Diabetic Diet\n\nReduce sugar, refined carbs, and oily foods.\n\n✔ Exercise Daily\n\nAt least 30 minutes walking or physical activity.\n\n✔ Monitor Blood Sugar\n\nCheck regularly as advised.\n\n✔ Stay Hydrated\n\nEspecially important with dapagliflozin.\n\n✔ Take Medicine Regularly\n\nDo not skip doses.\n\nWhy Choose DAPAVILDA MET 10/100/500?\n\nPatients and doctors prefer DAPAVILDA MET 10/100/500 because:\n\nTrusted triple therapy\nEffective glucose lowering\nSustained release convenience\nBetter compliance with one tablet\nSuitable for long-term diabetes management under supervision\nStorage Instructions\nStore in a cool, dry place\nKeep away from sunlight\nKeep out of reach of children\nStore below recommended temperature\nConclusion\n\nDAPAVILDA MET 10/100/500 containing Dapagliflozin 10 mg, Vildagliptin SR 100 mg and Metformin SR 500 mg Tablets is a highly effective triple-combination treatment for adults with type 2 diabetes. It helps lower blood sugar, improve insulin response, support weight control, and reduce long-term diabetes risks.",
"price": 325.0,
"discountamount": 98.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2393,
"imageuri": "https://productimages.withfloats.com/actual/69f1f2adf974f5424d3a55fa.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69f1f2adf974f5424d3a55fa.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-04-29T11:59:39.204Z",
"updatedon": "2026-04-29T11:59:39.204Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-mg-vildagliptin-sr-100-mg-and-metformin-sr-500-mg-tablets/2393",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "DAPAVILDA MET 10/100/500",
"category": "DIABETIC RANGE",
"tags": [
"Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}